Retatrutide is currently in phase 3 clinical trials and has not yet been approved by the U.S
Previous GLP-1 agonist cardiovascular trials were conducted primarily in diabetic populations, leaving open the question of whether the heart benefits were mediated through glucose management or through direct cardiovascular effects of GLP-1 receptor activation
Transport of L-carnitine in human corneal and conjunctival epithelial cells
Fatigue is one of the first signs of dehydration
*In the STEP 1 trial, participants received semaglutide 2.4 mg once weekly via subcutaneous injection, the FDA-approved formulation later marketed under the brand name Wegovy for chronic weight management in adults with obesity or overweight and at least one weight-related condition
"Muscle is what keeps your metabolism resilient, supports long-term weight maintenance and helps you move and feel strong in daily life," explains fitness entrepreneur and NSCA-certified trainer Megan Davies